Feb 16, 2023| JD Health

JD Health: CEO Shows Remarkable Reporting Card

Vivian Yang

by Vivian Yang

JD Health has become the “first entry point for online health consumption” in China, said Enlin Jin, CEO of JD Health during the company’s 3^rd partners’ meeting on Feb 10 in Beijing. The company is dedicated to providing access to all types of health consumption services in close collaboration with its partners, he added.

Data reveals that over the last three years, JD Health’s revenue has maintained a compound annual growth rate (CAGR) of 68 percent, while the average daily volume of online medical consultations and the annual number of active users both experienced CAGR growth of 48 and 213 percent, respectively.

As more users turn to JD Health Internet Hospital for dependable online medical care, it is expanding quickly. In the first half of 2022, the average daily consultation volume reached 250,000. Currently, the hospital has more than 45,000 doctors at the level of deputy chief physician and above, and has established 27 primary clinical departments and 151 secondary clinical departments.

On the aspect of pharmaceutical retailing, JD Pharmacy has grown by more than four times the industry average for the seventh consecutive year as of 2022. JD Pharmacy has accumulatively served over 100 million patients, and the DOT (i.e., duration of drug treatment) of patients with chronic diseases has been extended, which effectively improves the treatment impact on patients.

It is worth noting that in 2022, JD Health’s medical device user base surpassed 100 million, making it a stellar growth platform for many medical device brands. Among nearly 30,000 medical device brands from home and abroad that partnered with JD Health last year, over 40 brands had annual sales of over RBM 100 million yuan, and some top brands achieved annual sales of nearly RMB 2 billion yuan.

For nutrition and health care products, JD Health worked closely with brand partners to study user needs and propelled a 92 percent YoY sales increase among brand members. Meanwhile, JD Health offers the most comprehensive foods for special medical purposes (FSMP) online in the Chinese market.

On supply chain infrastructure, JD Health’s nationwide medicine warehouse network provides medicine storage service under all sorts of conditions in terms of different temperatures and dosage forms. It has achieved same-day delivery of products that are self-operated by JD Health teams in 146 cities and next-day delivery in 337 cities across China.

Highlighted during the partners’ meeting were four dimensions that will guide JD Health for the next development step to create fuller health service offerings to all people, including an open ecosystem, model expansion, service integration, and universal accessibility.

(vivian.yang@jd.com)

Dec 25, 2024| JD Health, JD Retail

JD Report: Five Health Consumption Trends for 2024

Vivian Yang

On December 24th, JD.com’s Consumption and Industry Development Research Institute, in collaboration with HealthInsight, a media think tank specializing in the health sector, released an insightful analysis of China’s 2024 health consumption landscape. The report outlines five key trends in the health industry, highlighting the increasing consumer demand for proactive health management and the industry’s evolving dynamics.

The Rise of Weight Management Solutions

Modern lifestyles have contributed to rising obesity rates with 34.3% of Chinese adults classified as overweight and 16.4% as obese. Obesity is associated with over 200 diseases, posing significant health risks. The introduction of semaglutide, a GLP-1 receptor agonist for long-term weight management, in China marks a promising development. The market for GLP-1 weight loss drugs in China is projected to exceed 37.852 billion RMB by 2030. On JD.com, searches related to “weight management” have increased more than 3.8 times year-on-year, with growing demand for diet products and home fitness equipment such as kettlebells and leg trainers.

Addressing the Growing Mental Health Concerns
With 95 million people in China affected by depression, mental health is an increasing concern. Consumers are turning to books, stress-relief toys, online consultations, and meditation to manage stress. On JD.com, searches for “mental health” have doubled, with significant interest in emotional release tools and psychological books. JD Health’s Internet Hospital now offers specialized clinics with over 2,300 counselors addressing issues like anxiety, depression, and sleep disorders.

The Booming Sleep Economy
Over 300 million Chinese experience sleep disorders, often due to irregular schedules. The sleep economy is booming with the market size reaching 495.58 billion RMB in 2023 and expected to surpass 600 billion RMB by 2027. JD.com has seen a 210% increase in searches for sleep aids, with high demand for sleep headphones, eye masks, and nutritional supplements. Sales of sleep-enhancing pillows and mattresses have also grown significantly.

Everyday Integration of Medical Devices

The home medical device market is expanding as consumers increasingly monitor their health independently. Products like heart rate-monitoring smartwatches and glucose meters are becoming household staples. This year, JD.com data shows that purchases of vision care devices and smart health monitoring equipment have tripled. The market for home medical devices is expected to reach 380 billion RMB by 2025.

Shifting Focus to Preventive Health Management

Emphasizing early screening and intervention, JD.com has seen a significant rise in orders for health services such as genetic testing and early cancer screening. These trends highlight a shift from treatment to prevention, driven by technological advancements and policy support. As consumer awareness grows, health consumption is becoming a major force in economic development, presenting opportunities for rapid growth in the health industry.

In conclusion, the 2024 health consumption landscape is characterized by a strong shift towards proactive health management and the integration of technology into everyday health practices. These trends not only reflect changing consumer priorities but also indicate significant growth opportunities for businesses in the health sector. JD.com remains committed to supporting these developments by providing innovative products and services tailored to the evolving needs of consumers across the dynamic health sector.

(vivian.yang@jd.com)

Dec 12, 2024| Global Partners/ Brands, JD Health

JD Health Debuts Merck’s New Diabetes Medication GLUCOPHAGE® XR (Reduce Mass) Online in China

Vivian Yang

On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering GLUCOPHAGE® XR (Reduce Mass), the metformin hydrochloride extended-release tablets, and became the first online pharmacy in China to provide the new antidiabetic medication developed by Merck. This launch signifies a major milestone in the partnership between JD Health and Merck, which is dedicated to enhancing the online availability and accessibility of innovative treatments for type 2 diabetes patients in China, thereby offering them a more convenient and effective medication experience.

GLUCOPHAGE® has been a cornerstone in the treatment of type 2 diabetes for over 60 years worldwide. The latest version of this medication is designed to enhance patient adherence by reducing the long-term burden of medication administration while maintaining its therapeutic benefits. The use of GSD sustained-release technology extends the time the medication remains in the stomach, reduces gastrointestinal irritation, and improves drug absorption. Additionally, the tablet is now smaller, has reduced volume by 30%, and has been transitioned from a capsule to a round shape, making it easier to swallow. It requires only once-daily administration, significantly enhancing patient convenience and safety.

To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at the 7th China International Import Expo in November. This event followed their partnership agreement in September, which also marked the opening of Merck China’s self-operated flagship store on JD.com.

With a large user base, robust supply chain, and rich medical service resources, JD Health has become a preferred partner to launch many chronic disease medications online. By seamlessly integrating online and offline resources, JD Health ensures that new drug information reaches the right users swiftly, offering convenient purchasing options and improving drug accessibility and usage efficiency. Additionally, JD Health’s extensive logistics network ensures timely and secure delivery of medications, enhancing user experience and building trust.

(vivian.yang@jd.com)

JD Cloud Launches ChatJD to Integrate ChatGPT into Technology Products and Services